Miscellaneous Topic
Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): A prospective study of 25 patients*

https://doi.org/10.1016/S0002-9149(84)80147-2Get rights and content

The presence, degree and frequency of disorders of cardiac conduction and rhythm and of regional or global myocardial dystrophy or myotonia have not previously been studied prospectively and systematically in the same population of patients with myotonic dystrophy. Accordingly, 25 adults with classic Steinert's disease underwent electrocardiography, 24-hour ambulatory electrocardiography, vectorcardiography, chest x-rays, echocardiography, electrophysiologic studies, and technetium-99m angiography. Clinically important cardiac manifestations of myotonic dystrophy reside in specialized tissues rather than in myocardium. Involvement is relatively specific, primarily assigned to the His-Purkinje system. The cardiac muscle disorder takes the form of dystrophy rather than myotonia, and is not selective, appearing with approximately equal distribution in all 4 chambers. Myocardial dystrophy seldom results in clinically overt ventricular failure, but may be responsible for atrial and ventricular arrhythmias. Since myotonic dystrophy is genetically transmitted, a primary biochemical defect has been proposed with complete expression of the gene toward striated muscle tissue, whether skeletal or cardiac. Specialized cardiac tissue and myocardium have close, if not identical, embryologic origins, so it is not surprising that the genetic marker affects both. Cardiac involvement is therefore an integral part of myotonic dystrophy, targeting particularly the infranodal conduction system, to a lesser extent the sinus node, and still less specifically, the myocardium.

References (50)

  • SanyalSK et al.

    Dystrophic degeneration of papillary muscle and ventricular myocardium: A basis for mitral valve prolapse in Duchenne's dystrophy

    Circulation

    (1980)
  • LudatscherRM et al.

    Myotonia dystrophica with heart involvement: an electron microscopic study of skeletal, cardiac, and smooth muscle

    J Clin Path

    (1978)
  • TanakaN et al.

    Cardiomyopathy in myotonic dystrophy: a light and electron microscopic study of the myocardium

    Jpn Heart J

    (1973)
  • SteinertH

    Uber das klinische und anatomische bild des muskelschwundes der myotoniker

    Deutsche Ztschr Nervenh

    (1909)
  • BattenFE et al.

    Myotonia atrophica

    Brain

    (1909)
  • GriffithTW

    On myotonia

    Q J Med

    (1911–1912)
  • EvansW

    The heart in myotonia atrophica

    Br Heart J

    (1944)
  • DeWindLT et al.

    Cardiovascular observations in dystrophia myotonica

    JAMA

    (1950)
  • HarperPS

    Myotonic Muscular Dystrophy

    HarperPS

    Myotonic Muscular Dystrophy

    HarperPS

    Myotonic Muscular Dystrophy

    HarperPS

    Myotonic Muscular Dystrophy

  • DodgePR et al.

    Myotonic dystrophy in infancy and childhood

    Pediatrics

    (1966)
  • ChurchSC

    The heart in myotonia atrophica

    Arch Intern Med

    (1967)
  • KomajdaM et al.

    Intracardiac conduction defects in dystrophia myotonica

    Brit Heart J

    (1980)
  • BlackWC et al.

    Studies in dystrophia myotonica. VII. Autopsy observations in five cases

    Arch Pathol

    (1947)
  • WintersSJ et al.

    Familial mitral valve prolapse and myotonic dystrophy

    Ann Intern Med

    (1976)
  • MorrisLK et al.

    Myotonic dystrophy, mitral valve prolapse, and cerebral embolism

    Stroke

    (1982)
  • Cited by (116)

    • Cardiovascular manifestations of neurologic disease

      2014, Handbook of Clinical Neurology
      Citation Excerpt :

      Cardiac involvement is very common in MMD and includes conduction abnormalities and structural heart disease as a result of interstitial myocardial fibrosis and myofibrillar degeneration (Motta et al., 1979). Electrocardiographic abnormalities are reported in 65–80% of patients, who most commonly experience PVCs, QRS prolongation, PR interval prolongation with atrioventricular block, and left fascicular block (Perloff et al., 1984; Groh et al., 2002). Atrial fibrillation and flutter are also commonly reported (Finsterer and Stollberger, 2008a).

    • 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the heart rhythm society

      2013, Journal of the American College of Cardiology
      Citation Excerpt :

      Permanent pacemaker implantation may be considered in the setting of neuromuscular diseases such as myotonic muscular dystrophy, Erb dystrophy (limb-girdle muscular dystrophy), and peroneal muscular atrophy with bifascicular block or any fascicular block, with or without symptoms. ( Level of Evidence: C) (91–97) Permanent pacemaker implantation is not indicated for fascicular block without AV block or symptoms. (

    • Cardiac Management in Neuromuscular Diseases

      2012, Physical Medicine and Rehabilitation Clinics of North America
      Citation Excerpt :

      These findings typically worsen over time in approximately 75% of patients. Rarely, dilated cardiomyopathy will be present in adults with DM1 or DM2.46–50 Recent MRI studies have shown fatty infiltration of the right ventricle in patients with ventricular tachydysrhythmias.51

    • A novel KCNQ1 variant (L203P) associated with torsades de pointes-related syncope in a steinert syndrome patient

      2011, Canadian Journal of Cardiology
      Citation Excerpt :

      However, several studies have reported the occurrence of sudden death in DM1 patients despite pacemaker implantation.5,7,15 These findings, together with descriptions of spontaneous or inducible ventricular tachycardias,5,7,9,16-19 contributed to the hypothesis that ventricular arrhythmias may play a causal role in the pathogenesis of sudden death in DM1 patients as well. Nonetheless, apart from two reports in the literature,20,21 Steinert syndrome–related QT interval prolongation and torsades de pointes appear to be extremely unusual.

    View all citing articles on Scopus
    *

    This study was supported by Grant E800421 from the Muscular Dystrophy Association, New York, New York, Clinical Research Center Grant R 1865 from the National Institutes of Health, Bethesda, Maryland, and by the Streisand Professorship/American Heart Association, Greater Los Angeles Affiliate, Los Angeles, California.

    View full text